Atsuko Takeuchi
Overview
Explore the profile of Atsuko Takeuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishigaki K, Takeuchi A, Taniguchi-Ikeda M, Sato T, Murakami T, Shichiji M, et al.
Sci Rep
. 2025 Feb;
15(1):6873.
PMID: 40011677
Treatment approaches are lacking for Fukuyama congenital muscular dystrophy (FCMD), the second most common type of pediatric muscular dystrophy after Duchenne muscular dystrophy (DMD) in the Japanese population. Recent studies...
2.
Fukuda A, Sato K, Fujimori C, Yamashita T, Takeuchi A, Ohuchi H, et al.
Science
. 2025 Jan;
387(6729):43-48.
PMID: 39745961
The recent discovery of nonvisual photoreceptors in various organs has raised expectations for uncovering their roles and underlying mechanisms. In this work, we identified a previously unrecognized hormone-releasing mechanism in...
3.
Yamada M, Maeta K, Suzuki H, Kurosawa R, Takenouchi T, Awaya T, et al.
Sci Rep
. 2024 Mar;
14(1):6506.
PMID: 38499569
Pathogenic variants in WDR45 on chromosome Xp11 cause neurodegenerative disorder beta-propeller protein-associated neurodegeneration (BPAN). Currently, there is no effective therapy for BPAN. Here we report a 17-year-old female patient with...
4.
Watanabe M, Nakamura K, Saito R, Takeuchi A, Takahashi T, Kitamoto T, et al.
Neuropathology
. 2023 May;
43(6):479-485.
PMID: 37165430
Genetic Creutzfeldt-Jakob disease (gCJD) with a V180I mutation (V180I gCJD) is the most common type of gCJD in Japan, characterized by an older age at onset, slower progression, and moderate...
5.
Noguchi Y, Bo R, Nishio H, Matsumoto H, Matsui K, Yano Y, et al.
Genes (Basel)
. 2023 Mar;
14(3).
PMID: 36981045
The authors wish to make the following correction to this paper [...].
6.
Kai H, Teruya K, Takeuchi A, Nakamura Y, Mizusawa H, Yamada M, et al.
Heliyon
. 2023 Mar;
9(3):e13974.
PMID: 36915552
The polymorphic heterozygosity of at codon 129 or 219 prevents the onset of sporadic Creutzfeldt-Jakob disease (sCJD). We investigated the association between polymorphic genotypes at codon 129 or 219 and...
7.
Kobayashi A, Hirata T, Shimazaki T, Munesue Y, Aoshima K, Kimura T, et al.
Acta Neuropathol
. 2023 Mar;
145(5):637-650.
PMID: 36879070
A missense variant from methionine to arginine at codon 232 (M232R) of the prion protein gene accounts for ~ 15% of Japanese patients with genetic prion diseases. However, pathogenic roles...
8.
Noguchi Y, Bo R, Nishio H, Matsumoto H, Matsui K, Yano Y, et al.
Genes (Basel)
. 2022 Nov;
13(11).
PMID: 36421785
Spinal muscular atrophy (SMA) is a common devastating neuromuscular disorder, usually involving homozygous deletion of the gene. Newly developed drugs can improve the motor functions of infants with SMA when...
9.
Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto-Vila M, Hosaka K, et al.
Elife
. 2022 Aug;
11.
PMID: 35913051
No abstract available.
10.
Niba E, Nishio H, Wijaya Y, Ar Rochmah M, Takarada T, Takeuchi A, et al.
Genes (Basel)
. 2022 Feb;
13(2).
PMID: 35205250
Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disease characterized by defects of lower motor neurons. Approximately 95% of SMA patients are homozygous for () gene deletion, while...